metformin has been researched along with Liver Cirrhosis, Biliary in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Liver Cirrhosis, Biliary: FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes.
Excerpt | Relevance | Reference |
---|---|---|
"Metformin treatment neither induced obvious hypoglycemic event nor altered hemodynamics in cirrhotic rats." | 1.46 | Metformin reduces intrahepatic fibrosis and intrapulmonary shunts in biliary cirrhotic rats. ( Chang, CC; Chuang, CL; Hsin, IF; Hsu, SJ; Huang, HC; Ko, MT; Lee, FY; Lee, SD; Lee, WS, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ko, MT | 1 |
Huang, HC | 1 |
Lee, WS | 1 |
Chuang, CL | 1 |
Hsin, IF | 1 |
Hsu, SJ | 1 |
Lee, FY | 1 |
Chang, CC | 1 |
Lee, SD | 1 |
1 other study available for metformin and Liver Cirrhosis, Biliary
Article | Year |
---|---|
Metformin reduces intrahepatic fibrosis and intrapulmonary shunts in biliary cirrhotic rats.
Topics: AMP-Activated Protein Kinases; Animals; Cyclooxygenase 1; Hepatopulmonary Syndrome; Liver Cirrhosis; | 2017 |